Authorisations for the following active substances have been extended due to delays in the re-evaluation for re-registration
Active Ingredient |
Limited until |
Reference |
Dimoxystrobin |
31.01.2021 |
https://eur-lex.europa.eu/legal-content/DE/ALL/?uri=CELEX:32019R2094 |
Mancozeb |
||
Mecoprop-P |
||
Metiram |
||
Oxamyl |
||
Pyraclostrobin |
||
Benfluralin |
28.02.2021 |
|
Fluazinam |
||
Flutolanil |
||
Mepiquat |